| Financial Year |
March 31 2023 |
| Monetary Funds |
30,442,487,807.49 |
| Held-for-trading Financial Assets |
8,235,290,071.58 |
| Notes Receivable |
-- |
| Accounts Receivable |
972,958,896.62 |
| Advances to Suppliers |
2,245,277,321.50 |
| Other Receivables |
4,003,757,077.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
170,297,345.06 |
| Dividend Receivable |
1,319,825.84 |
| Inventories |
29,537,765,614.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,438,927,892.02 |
| Other Current Assets |
3,621,348,002.43 |
| Total Current Assets |
82,387,085,435.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,084,861,683.08 |
| Investment Properties |
-- |
| Fixed Assetes |
27,642,428,469.02 |
| Under-construction Projects |
15,035,697,664.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,196,680,356.98 |
| R&D expenses |
-- |
| Goodwill |
417,326,849.47 |
| Long-Term Deferred and Prepaid Expenses |
207,648,709.24 |
| Deferred Income Tax Assets |
1,328,481,449.22 |
| Other Non-Current Assets |
10,968,250,999.33 |
| Sub-Total of Non-Current Assets |
80,617,461,287.78 |
| Total Assets |
163,004,546,723.53 |
| Short-Term Loans |
19,789,126,889.42 |
| Trading Financial liabilities |
2,558,691,232.66 |
| Notes Payable |
1,350,119,100.97 |
| Accounts Payable |
2,853,359,927.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,001,623,475.44 |
| Taxes Payable |
660,909,113.73 |
| Interest Payable |
58,578,534.28 |
| Dividend Payable |
27,885,796.68 |
| Other payables |
6,789,918,836.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,436,329,851.19 |
| Other Current Liabilities |
3,676,472,651.05 |
| Sub-Total of Current Liabilities |
47,560,132,835.10 |
| Long-term Loans |
20,050,932,692.21 |
| Bonds Payable |
2,194,173,013.76 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,267,636,804.29 |
| Deferred Income Tax Liabilities |
5,848,568,688.70 |
| Other Non-Current Liabilities |
22,475,835,081.15 |
| Sub-Total of Non-Current Liabilities |
54,502,971,297.74 |
| Total Liabilities |
102,063,104,132.84 |
| Paid-In Capital(Or Share Stock) |
4,319,848,116.60 |
| Capital Surplus |
27,698,228,576.58 |
| Surplus Reserve |
1,684,388,527.69 |
| LESS:Treasury Stock |
1,325,021,131.22 |
| Undistributed Profits |
18,337,014,479.38 |
| Minority Stockholder's Interest |
10,163,114,179.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
50,778,328,411.61 |
| Owner's Equity（Stockholder's Equity） |
60,941,442,590.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
163,004,546,723.53 |
